{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:38:41Z","timestamp":1781483921111,"version":"3.54.1"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,5,15]],"date-time":"2018-05-15T00:00:00Z","timestamp":1526342400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2018.00476","type":"journal-article","created":{"date-parts":[[2018,5,15]],"date-time":"2018-05-15T04:55:30Z","timestamp":1526360130000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":24,"title":["Linderane Suppresses Hepatic Gluconeogenesis by Inhibiting the cAMP\/PKA\/CREB Pathway Through Indirect Activation of PDE 3 via ERK\/STAT3"],"prefix":"10.3389","volume":"9","author":[{"given":"Wei","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangliang","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tifei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suling","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhua","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Leng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,5,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.bpobgyn.2013.02.007","article-title":"Glucose homeostasis, obesity and diabetes.","volume":"27","author":"Bano","year":"2013","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"k3240","DOI":"10.1172\/jci24867","article-title":"Alterations in regulation of energy homeostasis in cyclic nucleotide phosphodiesterase 3B-null mice.","volume":"116","author":"Choi","year":"2006","journal-title":"J. Clin. Invest."},{"key":"B3","doi-asserted-by":"publisher","first-page":"24336","DOI":"10.1074\/jbc.M602177200","article-title":"p38 Mitogen-activated protein kinase mediates free fatty acid-induced gluconeogenesis in hepatocytes.","volume":"281","author":"Collins","year":"2006","journal-title":"J. Biol. Chem."},{"key":"B4","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/0167-4889(84)90071-5","article-title":"Metabolic effects and cyclic AMP levels produced by glucagon, (1-N alpha-Trinitrophenylhistidine,12-homoarginine)glucagon and forskolin in isolated rat hepatocytes.","volume":"804","author":"Corvera","year":"1984","journal-title":"Biochim. Biophys. Acta"},{"key":"B5","author":"Duke","year":"1985","journal-title":"Medicinal Plants of China"},{"key":"B6","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.ab.2010.10.025","article-title":"An improved malachite green assay of phosphate: mechanism and application.","volume":"409","author":"Feng","year":"2011","journal-title":"Anal. Biochem."},{"key":"B7","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1152\/physrev.00030.2010","article-title":"Mammalian cyclic nucleotide phosphodiesterases: molecular mechanisms and physiological functions.","volume":"91","author":"Francis","year":"2011","journal-title":"Physiol. Rev."},{"key":"B8","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/978-90-481-3271-3_13","article-title":"Cyclic AMP signaling in pancreatic islets.","volume":"654","author":"Furman","year":"2010","journal-title":"Adv. Exp. Med. Biol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.2337\/diabetes.49.8.1367","article-title":"Influence of obesity and type 2 diabetes on gluconeogenesis and glucose output in humans: a quantitative study.","volume":"49","author":"Gastaldelli","year":"2000","journal-title":"Diabetes Metab. Res. Rev."},{"key":"B10","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.cmet.2015.07.027","article-title":"Hepatic mitochondrial pyruvate carrier 1 is required for efficient regulation of gluconeogenesis and whole-body glucose homeostasis.","volume":"22","author":"Gray","year":"2015","journal-title":"Cell Metab."},{"key":"B11","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.cell.2009.03.016","article-title":"Metformin and insulin suppress hepatic gluconeogenesis through phosphorylation of CREB binding protein.","volume":"137","author":"He","year":"2009","journal-title":"Cell"},{"key":"B12","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0898-6568(98)00003-5","article-title":"Combined effects of insulin and dexamethasone on cyclic AMP phosphodiesterase 3 and glycogen metabolism in cultured rat hepatocytes.","volume":"10","author":"Hermsdorf","year":"1998","journal-title":"Cell. Signal."},{"key":"B13","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/35093131","article-title":"CREB regulates hepatic gluconeogenesis through the coactivator PGC-1.","volume":"413","author":"Herzig","year":"2001","journal-title":"Nature"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1007\/s00125-007-0622-3","article-title":"Effect of a novel non-thiazolidinedione peroxisome proliferator-activated receptor alpha\/gamma agonist on glucose uptake.","volume":"50","author":"Hu","year":"2007","journal-title":"Diabetologia"},{"key":"B15","doi-asserted-by":"crossref","first-page":"5353","DOI":"10.1016\/S0021-9258(18)53327-5","article-title":"Glucocorticoid receptor-cAMP response element-binding protein interaction and the response of the phosphoenolpyruvate carboxykinase gene to glucocorticoids.","volume":"268","author":"Imai","year":"1993","journal-title":"J. Biol. Chem."},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10856","article-title":"AMPK antagonizes hepatic glucagon-stimulated cyclic AMP signalling via phosphorylation-induced activation of cyclic nucleotide phosphodiesterase 4B.","volume":"7","author":"Johanns","year":"2016","journal-title":"Nat. Commun."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1007\/s00125-016-3940-5","article-title":"Hepatic glucose and lipid metabolism.","volume":"59","author":"Jones","year":"2016","journal-title":"Diabetologia"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0113170","article-title":"Deep sequencing of the murine olfactory receptor neuron transcriptome.","volume":"10","author":"Kanageswaran","year":"2015","journal-title":"PLoS One"},{"key":"B19","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2174\/1874467211003010037","article-title":"EGFR-targeted therapy in malignant glioma: novel aspects and mechanisms of drug resistance.","volume":"3","author":"Lo","year":"2010","journal-title":"Curr. Mol. Pharmacol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/nature11808","article-title":"Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP.","volume":"494","author":"Miller","year":"2013","journal-title":"Nature"},{"key":"B21","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3164\/jcbn2007019","article-title":"Antioxidant activities of uyaku (Lindera strychnifolia) leaf extract: a natural extract used in traditional medicine.","volume":"41","author":"Noda","year":"2007","journal-title":"J. Clin. Biochem. Nutr."},{"key":"B22","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/nrendo.2013.256","article-title":"Metformin\u2013mode of action and clinical implications for diabetes and cancer.","volume":"10","author":"Pernicova","year":"2014","journal-title":"Nat. Rev. Endocrinol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/nrendo.2017.80","article-title":"Regulation of hepatic glucose metabolism in health and disease.","volume":"13","author":"Petersen","year":"2017","journal-title":"Nat. Rev. Endocrinol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.cmet.2016.01.004","article-title":"HIF2alpha is an essential molecular brake for postprandial hepatic glucagon response independent of insulin signaling.","volume":"23","author":"Ramakrishnan","year":"2016","journal-title":"Cell Metab."},{"key":"B25","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1159\/000445523","article-title":"Hypothalamic phosphodiesterase 3B pathway mediates anorectic and body weight-reducing effects of insulin in male mice.","volume":"104","author":"Sahu","year":"2017","journal-title":"Neuroendocrinology"},{"key":"B26","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.peptides.2015.08.011","article-title":"Leptin receptor expressing neurons express phosphodiesterase-3B (PDE3B) and leptin induces STAT3 activation in PDE3B neurons in the mouse hypothalamus.","volume":"73","author":"Sahu","year":"2015","journal-title":"Peptides"},{"key":"B27","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/S0092-8674(01)00239-2","article-title":"New perspectives into the molecular pathogenesis and treatment of type 2 diabetes.","volume":"104","author":"Saltiel","year":"2001","journal-title":"Cell"},{"key":"B28","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1172\/jci77812","article-title":"The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux.","volume":"126","author":"Samuel","year":"2016","journal-title":"J. Clin. Invest."},{"key":"B29","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0092-8674(00)80709-6","article-title":"Deconstructing type 2 diabetes.","volume":"97","author":"Taylor","year":"1999","journal-title":"Cell"},{"key":"B30","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.1002\/1873-3468.12740","article-title":"A compendium of ERK targets.","volume":"591","author":"Unal","year":"2017","journal-title":"FEBS Lett."},{"key":"B31","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1172\/jci60016","article-title":"Glucagonocentric restructuring of diabetes: a pathophysiologic and therapeutic makeover.","volume":"122","author":"Unger","year":"2012","journal-title":"J. Clin. Invest."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.3109\/00498254.2015.1041002","article-title":"Mechanism-based inactivation of CYP2C9 by linderane.","volume":"45","author":"Wang","year":"2015","journal-title":"Xenobiotica"},{"key":"B33","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1248\/bpb.27.789","article-title":"Orthovanadate stimulates cAMP phosphodiesterase 3 activity in isolated rat hepatocytes through mitogen-activated protein kinase activation dependent on cAMP-dependent protein kinase.","volume":"27","author":"Watanabe","year":"2004","journal-title":"Biol. Pharm. Bull."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1002\/jssc.200900768","article-title":"Separation and quantitative determination of sesquiterpene lactones in Lindera aggregata (wu-yao) by ultra-performance LC-MS\/MS.","volume":"33","author":"Wu","year":"2010","journal-title":"J. Sep. Sci."},{"key":"B35","doi-asserted-by":"publisher","first-page":"R93","DOI":"10.1530\/JME-15-0316","article-title":"Targeting cAMP\/PKA signaling pathway for glycemic control and type 2 diabetes therapy.","volume":"57","author":"Yang","year":"2016","journal-title":"J. Mol. Endocrinol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1002\/ptr.5676","article-title":"Two alkaloids from bulbs of Lycoris sanguinea MAXIM. Suppress PEPCK expression by Inhibiting the Phosphorylation of CREB.","volume":"30","author":"Yun","year":"2016","journal-title":"Phytother. Res."},{"key":"B37","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.cmet.2009.03.012","article-title":"AMPK: an emerging drug target for diabetes and the metabolic syndrome.","volume":"9","author":"Zhang","year":"2009","journal-title":"Cell Metab."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fphar.2018.00476\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,23]],"date-time":"2022-08-23T18:08:56Z","timestamp":1661278136000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fphar.2018.00476\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,15]]},"references-count":37,"alternative-id":["10.3389\/fphar.2018.00476"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2018.00476","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,15]]},"article-number":"476"}}